Christina Curtis, Associate Professor of Oncology and Genetics at Stanford
0:00 Tumors that are “born to be bad”
6:48 Big Bang Theory of cancer
10:10 Spatial technology is putting tumor evolution in context
15:05 Longitudinal HER2 study successfully predicted which patients would respond to therapy
20:17 What are your thoughts on early cancer detection?
24:35. Low hanging genomic fruit has been plucked but still many opportunities
If one was going to be a cancer researcher, surely one would want to be Christina Curtis. She’s an associate professor of oncology and genetics at Stanford, and she studies tumor evolution. She’s the Darwin of cancer research.
Because scientists can’t see human tumors evolve in real life, in Christina's lab she creates what she calls "virtual tumors that recapitulate the size and spatial properties of an actual tumor. And evaluating patient data,” she says, "we have found that metastatic seeding could happen very early. That these tumors were born to be bad.”
No wonder that Christina was an early adopter for spatial technology where she can see actual tumors in context. What’s particularly great about her work is that she not only explores basic science on the one end, but is studying patients in treatment as well.